Video·3 min read·May 2026

The Healing Power of Cold: How Cryotherapy Can Support Cancer Recovery

Cold Therapy • 3 min read • Based on research by Hideo Shigematsu, Taizo Hirata, Mai Nishina, Daisuke Yasui, Shinji Ozaki (2020)

For many, the journey through cancer treatment can feel overwhelming. The physical and emotional toll of chemotherapy, particularly with drugs like paclitaxel, can lead to a host of side effects that significantly impact quality of life. Among these, peripheral neuropathy—a condition that causes numbness, tingling, and pain in the hands and feet—can be particularly distressing.

Recent research sheds light on an innovative approach to mitigate these adverse effects: cryotherapy. By harnessing the benefits of cold exposure, this method offers promising support for those undergoing chemotherapy, allowing for a more balanced and resilient recovery process.

Understanding Cryotherapy

Cryotherapy involves exposing the body to cold temperatures, which can stimulate various physiological responses. In the context of cancer treatment, it acts by reducing blood flow and inflammation in the peripheral nerves. This suppression of circulation can help protect against nerve damage often associated with chemotherapy drugs like paclitaxel.

In a recent study, 44 breast cancer patients were divided into two groups: one receiving cryotherapy and the other a control group. The results were compelling. Patients who underwent cryotherapy experienced a significant reduction in the incidence of peripheral neuropathy and skin-related side effects, with 41% showing marked improvement compared to 73% in the control group. These findings suggest that cryotherapy can serve as an effective adjunctive treatment during chemotherapy.

The Science Behind the Benefits

The study's primary endpoint was the percentage of patients with a marked decrease in the Functional Assessment of Cancer Therapy-Neurotoxicity (FACT-NTX) score, a measure of neurotoxicity. Results indicated that cryotherapy not only reduced the risk of sensory and motor peripheral neuropathy but also led to a decrease in dermatological adverse events, such as skin inflammation and nail changes.

Specifically, the incidence of sensory neuropathy graded as 2 or higher was significantly lower in the cryotherapy group (p = 0.001), demonstrating the potential of cold exposure to enhance the overall treatment experience. The absence of serious side effects associated with cryotherapy further supports its accessibility as a wellness protocol during cancer treatment.

Practical Applications for Wellness

Integrating cryotherapy into a cancer treatment regimen may provide a sanctuary for patients seeking to maintain equilibrium during their journey. The research suggests that not only does cryotherapy help alleviate some of the more challenging side effects of chemotherapy, but it also fosters resilience by enhancing the overall quality of life.

As we continue to explore the broader applications of cryotherapy in various therapeutic contexts, it becomes clear that this cold therapy can be a valuable tool for anyone looking to enhance their recovery and well-being. Whether you are a patient, caregiver, or wellness enthusiast, understanding these benefits can empower you to make informed choices about your health.

Key Takeaways

Cryotherapy can significantly reduce the incidence of peripheral neuropathy and dermatological adverse events in breast cancer patients undergoing chemotherapy.
Integrating cryotherapy as part of a treatment protocol may enhance recovery and improve quality of life, making it a valuable tool for those navigating cancer care.

Based on: Cryotherapy for the prevention of weekly paclitaxel-induced peripheral adverse events in breast cancer patients
Hideo Shigematsu, Taizo Hirata, Mai Nishina, Daisuke Yasui, Shinji Ozaki (2020). Supportive Care in Cancer

Contrast Collective • Science-backed wellness

Wim's Wise Words

A second take, from someone who's lived it.

🧊 Wim's Wise Words

Cryotherapy for the prevention of weekly paclitaxel-induced peripheral

The Core Claim

This is a small but clean randomized trial — 44 breast cancer patients, weekly paclitaxel, frozen gloves and socks worn for 90 minutes centered around each infusion. The result: 41% of the cryotherapy group showed meaningful decline in nerve function scores, versus 73% in the control group. Grade 2 or higher sensory neuropathy was also significantly lower. No serious side effects. The conclusion is straightforward — targeted cold exposure during chemotherapy protects peripheral nerves from drug-induced damage.

That's the claim. And it's a good one. Not a massive trial, but the mechanism is credible and the numbers are hard to argue with.

The Mechanism — And Why It Matters Here

Here's what's actually happening. Paclitaxel is a taxane chemotherapy agent — it works by disrupting cell division, which is exactly what you want when you're targeting a tumor. But it doesn't stay neatly inside the tumor. It circulates systemically. The peripheral nerves in your hands and feet — the ones farthest from your core, already the most vulnerable — absorb cumulative drug load across 12 weekly treatments. That's where neuropathy comes from. Numbness, tingling, pain. It can persist in 50 to 80% of patients even after treatment ends.

Frozen gloves and socks at negative 20 degrees Celsius cause intense vasoconstriction. Blood flow to the extremities drops sharply. Less blood flow means less paclitaxel reaching the peripheral nerve endings during peak infusion. The cold is creating a kind of pharmacological barrier — not blocking treatment, but shielding the tissue that treatment isn't meant to target.

Cold doesn't just recover tissue. In the right context, it protects tissue that shouldn't be touched in the first place.

Where the Research Stands

This isn't a novel idea — there are retrospective studies and self-controlled trials pointing in the same direction. Compression therapy using surgical gloves has shown similar effects. What this paper adds is the randomized design, which matters a lot when you're trying to establish causation rather than correlation. The effect sizes here are clinically meaningful, not marginal. And the absence of serious side effects associated with the cold itself is important — frostbite and eczema were monitored, and compliance was reasonable at 68% good compliance across 12 weekly sessions.

The limitation is the scale. Forty-four patients. Phase II. You'd want a larger trial before making this standard of care. But as a proof of concept, it's compelling. And given that there are currently no established medications for preventing taxane-induced peripheral neuropathy, this fills a genuine gap.

The Practical Recommendation

If you or someone close to you is navigating a weekly paclitaxel regimen for breast cancer, this is a conversation worth having with your oncologist. The intervention is simple — commercially available frozen glove and sock products like Elasto-Gel, worn for 90 minutes per session. The evidence is controlled, the risk profile is low, and neuropathy is one of the most common reasons for dose reduction or treatment disruption. Protecting your quality of life during treatment is as important as the treatment itself.

The Surprising Connection

We talk about cold exposure constantly in this space — ice baths, cold plunges, contrast therapy — almost always framed around recovery and adaptation. The cold is the stressor, and the benefit comes afterward, in the rebound. But this paper flips that entirely. Here, the cold isn't building resilience. It's creating selective protection. It's asking the body to temporarily withdraw from a region so that region doesn't absorb collateral damage from something passing through the bloodstream.

The same vasoconstriction that makes a cold plunge uncomfortable — that initial sharp retreat of blood from the extremities — is being put to work as a shield. It's the same physiological lever, pulled for a completely different purpose. Cold as sanctuary, not just cold as stimulus. That reframing alone is worth sitting with.

Cryotherapy for the prevention of weekly paclitaxel-induced peripheral

The Healing Power of Cold: How Cryotherapy Can Support Cancer Recovery

Understanding Cryotherapy

The Science Behind the Benefits

Practical Applications for Wellness

Key Takeaways

Related articles

Cryotherapy for Prevention of Taxane-Induced Peripheral Neuropathy: A Meta-Analysis

Impact of Cryotherapy on Sensory, Motor, and Autonomic Neuropathy in Breast Cancer Patients Receiving Paclitaxel: A Randomized, Controlled Trial

Use of Cryotherapy for Managing Chronic Pain An Evidence-Based Narrative